Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathology | 2 | 2016 | 41 | 0.460 |
Why?
|
| Scientific Misconduct | 1 | 2013 | 6 | 0.440 |
Why?
|
| Authorship | 1 | 2013 | 28 | 0.430 |
Why?
|
| Publishing | 1 | 2013 | 104 | 0.400 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 212 | 0.290 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2005 | 28 | 0.250 |
Why?
|
| Internship and Residency | 3 | 2016 | 1153 | 0.240 |
Why?
|
| Proto-Oncogenes | 1 | 2004 | 37 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2004 | 53 | 0.230 |
Why?
|
| Trans-Activators | 2 | 2005 | 805 | 0.230 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 483 | 0.220 |
Why?
|
| Breast | 1 | 2004 | 214 | 0.210 |
Why?
|
| Carcinoma | 1 | 2004 | 279 | 0.200 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2002 | 53 | 0.200 |
Why?
|
| Breast Neoplasms | 2 | 2004 | 2478 | 0.180 |
Why?
|
| Hodgkin Disease | 2 | 2019 | 289 | 0.180 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 2032 | 0.170 |
Why?
|
| Pathologists | 2 | 2016 | 29 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2020 | 808 | 0.160 |
Why?
|
| Immunoassay | 1 | 1997 | 126 | 0.140 |
Why?
|
| Biostatistics | 1 | 2016 | 10 | 0.140 |
Why?
|
| Chemistry, Clinical | 1 | 2016 | 13 | 0.140 |
Why?
|
| Immunohistochemistry | 4 | 2005 | 1710 | 0.110 |
Why?
|
| Deception | 1 | 2013 | 11 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 628 | 0.110 |
Why?
|
| Publications | 1 | 2013 | 31 | 0.110 |
Why?
|
| Job Application | 1 | 2013 | 17 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 800 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 638 | 0.090 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 9 | 0.080 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2008 | 12 | 0.080 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2008 | 15 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 138 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 194 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 2 | 2005 | 217 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2005 | 6275 | 0.060 |
Why?
|
| Cyclin D | 1 | 2005 | 6 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2005 | 14 | 0.060 |
Why?
|
| Cyclins | 1 | 2005 | 104 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 101 | 0.060 |
Why?
|
| Humans | 14 | 2020 | 121793 | 0.060 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 35 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2005 | 1616 | 0.060 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2004 | 24 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2004 | 81 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 2004 | 69 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2020 | 332 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 165 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 33 | 0.050 |
Why?
|
| Aged | 5 | 2019 | 18732 | 0.050 |
Why?
|
| Aminoglycosides | 1 | 2002 | 44 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2004 | 402 | 0.050 |
Why?
|
| Axilla | 1 | 2002 | 38 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 137 | 0.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2003 | 184 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 3297 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 261 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2002 | 421 | 0.040 |
Why?
|
| Rabbits | 2 | 1998 | 717 | 0.040 |
Why?
|
| Middle Aged | 6 | 2005 | 25516 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2002 | 377 | 0.040 |
Why?
|
| Leukemia | 1 | 2002 | 357 | 0.040 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1998 | 27 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 715 | 0.040 |
Why?
|
| Cell Extracts | 1 | 1997 | 11 | 0.040 |
Why?
|
| Hemagglutination Tests | 1 | 1997 | 11 | 0.040 |
Why?
|
| United States | 1 | 2013 | 10413 | 0.040 |
Why?
|
| Salts | 1 | 1997 | 9 | 0.040 |
Why?
|
| Buffers | 1 | 1997 | 32 | 0.040 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1997 | 11 | 0.040 |
Why?
|
| Plastics | 1 | 1997 | 16 | 0.040 |
Why?
|
| Adult | 5 | 2005 | 28549 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1414 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2829 | 0.040 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1997 | 113 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 425 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1881 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 3601 | 0.030 |
Why?
|
| Comprehension | 1 | 2016 | 73 | 0.030 |
Why?
|
| Epitopes | 1 | 1997 | 429 | 0.030 |
Why?
|
| Female | 5 | 2005 | 64573 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 507 | 0.020 |
Why?
|
| Male | 4 | 2019 | 59243 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2003 | 1463 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2008 | 26 | 0.020 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2008 | 40 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 2008 | 35 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2008 | 56 | 0.020 |
Why?
|
| Azacitidine | 1 | 2008 | 55 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 98 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2008 | 167 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 750 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 2792 | 0.020 |
Why?
|
| Animals | 3 | 2008 | 33870 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 123 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 659 | 0.010 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Immunotoxins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 290 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 231 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 860 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2002 | 137 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 1105 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 679 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1933 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 999 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 1396 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1736 | 0.010 |
Why?
|
| Isoantigens | 1 | 1998 | 18 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1998 | 69 | 0.010 |
Why?
|
| Blood Group Incompatibility | 1 | 1998 | 27 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2002 | 501 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 2580 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1998 | 207 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 1976 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2003 | 12003 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1998 | 301 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1021 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 1007 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 4953 | 0.010 |
Why?
|
| Prognosis | 1 | 2003 | 4438 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 1672 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6168 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 5960 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 17624 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 2389 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 4306 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1998 | 8009 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 18773 | 0.000 |
Why?
|
| Child | 1 | 2003 | 23789 | 0.000 |
Why?
|